Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ST 502

Next Previous
Drug Profile

ST 502

Alternative Names: ST-502

Latest Information Update: 29 Feb 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sangamo Therapeutics
  • Developer Biogen; Sangamo Therapeutics
  • Class Antiparkinsonians; Gene therapies; Zinc finger DNA binding proteins
  • Mechanism of Action Alpha-synuclein inhibitors; Genetic transcription inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Parkinson's disease

Highest Development Phases

  • Preclinical Parkinson's disease

Most Recent Events

  • 29 Feb 2024 Preclinical trials in Parkinson's disease in USA (Parenteral) (Sangamo Therapeutics Pipeline, February 2024)
  • 15 May 2023 Discontinued - Preclinical for Parkinson's disease in USA (Parenteral) (Sangamo Therapeutics pipeline; May 2023)
  • 31 Mar 2023 Biogen notifies Sangamo Therapeutics of its licensing agreement termination for convenience, effective from June 2023

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top